| Literature DB >> 36262492 |
Omair Khan1, Sheharyar Raashid2, Muhammad Hashim3, Kevin Clements1, Sanjay Maheshwari1, Syed M Mazhar Uddin1, Pranay Siriya1, Aftab Vadsariya1, Patricia Park4, William Pascal5.
Abstract
Adrenocortical carcinoma (ACC) is a rare malignancy with an estimated annual incidence of 0.7-2 cases per million. Most patients present with steroid hormone excess or abdominal mass effects, but 15% of patients with ACC are diagnosed incidentally. A careful history, physical exam, and pertinent lab investigations are necessary to reach the diagnosis. Surgical resection is the cornerstone of treatment in localized ACC; however, systemic chemotherapy with mitotane is preferred in patients with widespread disease or those who are not ideal candidates for surgery.Entities:
Keywords: Adrenal cancer; Adrenal mass; Cushingoid adrenal cancer; Hypercortisolism
Year: 2022 PMID: 36262492 PMCID: PMC9529648 DOI: 10.55729/2000-9666.1108
Source DB: PubMed Journal: J Community Hosp Intern Med Perspect ISSN: 2000-9666